Skip to content

NCBIO Legislative Reception June 22

Join NCBIO members and legislators for an evening reception highlighting the state’s life sciences industry and discuss workforce training, life science program funding, innovation and tax policy and other topics of interest with law makers.

Biotech joins efforts to aid in humanitarian relief in Ukraine

The biotech industry is coming together to donate a range of critical medical supplies, equipment and medications to the people of Ukraine.

NCBIO Roadmap to Diversity Event

“Our workforces are more dynamic. They're more empowered, they're more enlightened, and they want answers not just from the standpoint of their functional skills and capabilities in our business performance. But also what is it that our company stands for?” -- Keynote speaker Celeste Warren, VP, Merck Global Diversity and Inclusion Center

Bio Business Solutions

NCBIO Members Save Big with BIO Business Solutions

BIO Business Solutions offers NCBIO members the opportunity to pool their purchasing power with other life science companies nationwide to command significant discounts for frequently used products and services.

Bio Business Solutions

NCBIO, the North Carolina Biosciences Organization

NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.

Member Benefits

A variety of discount programs are available to members.

BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy

April 8, 2022

On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the…

Read More

Biotech joins efforts to aid in humanitarian relief in Ukraine

March 4, 2022

The biotech and life sciences industry is coming together to donate a range of critical medical supplies, equipment, and medications…

Read More

CMS decision not to cover Alzheimer’s treatment a bad one

March 2, 2022

NCBIO stands in solidarity with patient advocates and industry leaders in opposing the Centers for Medicare and Medicaid Services’ draft…

Read More

Who pays to create new medicines?

January 13, 2022

Does government spending on drug development justify government price controls on medicines? Not when the private sector spends $102 billion on clinical R&D and the NIH spends less than $3 billion.

Read More
NCBIO President Laura Gunter and Sam Taylor's wife, Nancy Reed, at the opening of Wake Tech’s Lilly Science and Technology Center

Lead gifts from Alexandria Real Estate, Biogen, Hatteras push Taylor scholarship fund past $200,000

April 8, 2022

The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners.

Read More

NCBIO forum explores moving technology through funding phases

March 21, 2022

A high quality board of directors and valuable outside partnerships are two advantages that biotech startups would do well to cultivate, according to the expert panelists assembled for the NCBIO Emerging Company and Technology Forum held Wednesday, March 16, at the NC Biotechnology Center.

Read More
Drew Duncan (Biogen), Erica Paine (Chiesi USA), Sheila Mikhail (AskBio) with Nicole Thompson (BD) participating remotely

NCBIO Roadmap to Diversity event offers guidance for member DEI initiatives

March 18, 2022

NCBIO members gathered at the NC Biotechnology Center Wednesday, March 9, to seek inspiration and guidance in pursuing their companies’ diversity, equity and inclusion goals. Some key takeaways from the discussions included the need to weave DEI into everything the company does; it can’t stand alone.

Read More
Scott Ewing, Lilly

BMF presenters share lessons learned commissioning facilities during pandemic

February 25, 2022

At the NCBIO Biomanufacturers Forum held online Feb. 23, representatives from FUJIFILM Diosynth Biotechnologies, Lilly and Project Farma shared what they had learned about commissioning new facilities and equipment during the during the COVID-19 pandemic.

Read More

Sustaining Members

Pfizer logo

Supporting Members